Table 1.
Patient characteristics
| Patients | Controls | Normal values | |
|---|---|---|---|
| Gender (M/F) | 15/14 | 10/9 | |
| Age (years) | 35 (24–50) | 44 (38–57) | |
| BMI | 23.0 (20.6–24.1) | ||
| Amylase (U/L) | 43 (25–59) | 10–65 | |
| Lactatdehydrogenase (U/L) | 161 (136–180) | 105–205 | |
| ALT (U/L) | 39 (24–75) | 10–70 | |
| Bilirubin (umol/L) | 9 (8–14) | 5–25 | |
| Alkaline phosphatase (U/L) | 96 (74–125) | 35–105 | |
| PP factor 2, 7, 10 | 0.82 (0.69-0.90) | 0.6-1.30 | |
| Potassium (mmol/L) | 4.0 (3.8–4.1) | 3.5–4.6 | |
| Sodium (mmol/L) | 140 (139–142) | 137–145 | |
| Albumine (g/L) | 38 (36–41) | 36–48 | |
| Creatinine (umol/L) | 69.0 (60.0–87.0) | 45–105 | |
| eGFR (mL/min 1.73m2) | 91 (89–91) | > 60 | |
| B-leukocytes (10^9/l) | 6.1 (5.1–6.5) | 3.5–10.0 | |
| Haemoglobin (mmol/L) | 8.9 (8.2–9.2) | 7.3–10.5 | |
| Platelets (10^9/L) | 204 (151–242) | 165–400 | |
| Iron (umol/L) | 15 (12–21) | 9–34 | |
| Transferrin (umol/L) | 34 (31–37) | 24–41 | |
| Transferrin-saturation | 0.3 (0.2–0.3) | 0.10–0.57 | |
| Haptoglobin (g/L) | 0.9 (0.6–1.3) | 0.35–1.85 | |
| Zinc in blood (umol/L) | 17 (12–25) | 10–19 | |
| Zinc in 24-h urine (umol/24 h) | 37.10 (16.00–68.25) | 6–12 | |
| Copper in 24-h urine (umol/24 h) | 5.3 (1.7–8.1) | 0–1.5 | |
| MELD-score | 8 (7–9) |
Parameters are presented as medians (interquartile range). BMI, body mass index; ALT, alanine transferase; MELD, Model of End-stage Liver Disease